Fellows will spend one year in clinical training which includes three months on the Transplant ID service followed by three years of advanced training in the care of transplant / immunocompromised hosts (ICH) and innovative methods of scientific research in this population. Trainees on this track will spend 6 months on the Transplant ID clinical service during their second year and the remaining 2.5 years performing clinical or basic science research focused on transplant/ICH in one of four key areas: 1) laboratory medicine, 2) microbial epidemiology & pathogenesis, 3) host susceptibility & response to infection, or 4) medical management & treatment outcomes.
The research expertise and resources available to Transplant ID trainees at Duke are considerable. Twenty-two faculty with primary appointments in six departments participate in the training program.
The goal of the Transplant/ICH track is to train physician-scientists to assume leadership and investigate roles related to infectious diseases in the ICH.
Clinical and Basic Science Research Opportunities and Mentors for each category:
- L. Barth Reller, MD, DTM&H
- Barbara D. Alexander, MD, MHS
Microbial Epidemiology and Pathogenesis
- Bryan R. Cullen, PhD
- Micah Luftig, PhD
- Joseph Heitman, MD, PhD
- John R. Perfect, MD
- J. Andrew Alspaugh, MD
- Fred S. Dietrich, PhD
- Daniel J. Sexton, MD
- Deverick J. Anderson, MD, MPH
Host Susceptibility and Response to Infection
- Geoffrey S. Ginsburg, MD, PhD
- Aimee K. Zaas, MD, MHS.
- David B. Goldstein, PhD
- Barton F. Haynes, MD
- Kent J. Weinhold, PhD
- Georgia D. Tomaras, PhD
- M. Anthony Moody, MD
Medical Management & Treatment Outcomes
- G. Ralph Corey, MD
- Scott M. Palmer, MD, MHS
- Cameron R. Wolfe, MBBS